Metformin Induces Ultrastructural Alterations in Hepatocytes of Spontaneously Hypertensive Rats
Metformin, an oral biguanide approved for the treatment of type II diabetes is widely prescribed for other clinical conditions. Currently, metformin is being investigated as potential anti-tumor agent. However, there have been recent concerns about hepatotoxicity associated with the use of metformin...
Guardado en:
Autor principal: | Gharbaran,Rajendra |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad Chilena de Anatomía
2014
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-95022014000300016 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Metformin Pretreatment Ameliorates Diabetic Nephropathy Induced by a Combination of High Fat Diet and Streptozotocin in Rats
por: Dallak,Mohammad, et al.
Publicado: (2018) -
Inhibition of Diabetes Mellitus-Induced Knee Joint Injury in Rats by a Combination of Metformin and Captopril
por: El-Bidawy,Mahmoud H, et al.
Publicado: (2021) -
Metformin Protects Against Thioacetamide Induced Liver injury in Rats
por: Al-Hashem,Fahaid, et al.
Publicado: (2018) -
Ultrastructure of the Myelinated and Unmyelinated Nerve Fibers of the Tongue Mucosa of Albinus Rat (Wistar) with Aging
por: Grisolia,D. F., et al.
Publicado: (2006) -
Suppression of L-Arginine-Induced Acute Necrotizing Pancreatitis in Rats by Metformin Associated with the Inhibition of Myeloperoxidase and Activation of Interleukin-10
por: Al-Hashem,Fahaid
Publicado: (2021)